Literature DB >> 22200369

Early and late outcome after aortic root replacement with a mechanical valve prosthesis in a series of 528 patients.

Bart P van Putte1, Sabri Ozturk, Sailay Siddiqi, Marc A A M Schepens, Robin H Heijmen, Wim J Morshuis.   

Abstract

BACKGROUND: Aortic root replacement with a mechanical valve prosthesis is a widely accepted surgical technique. This study aims to evaluate short-term and long-term outcomes of this approach and to identify predictors of 30-day mortality.
METHODS: We retrospectively analyzed a consecutive series of 528 patients (mean age, 54±13 years) who underwent aortic root replacement for aneurysm (83%), acute type A dissection (15%), or endocarditis (2%) in the period between 1974 and 2008. The mean time of follow-up was 9.0±7.0 years (range, 0 to 36 years). Concomitant aortic surgery was performed in 71%, coronary revascularization in 18%, and mitral valve surgery in 3%. Selective antegrade cerebral perfusion was applied in 25% and deep hypothermic circulatory arrest in 28% of patients.
RESULTS: Overall 30-day mortality was 3.2% to 2.5% for elective surgery and 6.5% for urgent surgery. Morbidity included resternotomy for bleeding or tamponade (19%), pacemaker implantation (3.6%), myocardial infarction (4.0%), and neurologic damage (4.2%). Multivariate analysis revealed myocardial infarction (p<0.001) and the lack of glue use (p=0.018) as independent predictors of 30-day mortality. Subanalysis of the selective antegrade cerebral perfusion patients and the deep hypothermic circulatory arrest patients revealed infarction (p=0.005) and coronary artery disease (p=0.45) for selective antegrade cerebral perfusion and wrapping (p=0.035) for deep hypothermic circulatory arrest as independent risk factors. The survival rate was 87%, 73%, and 29% after 5, 10, and 25 years, respectively.
CONCLUSIONS: Aortic root replacement with a mechanical valve prosthesis can be performed safely with low mortality and acceptable morbidity. Perioperative myocardial infarction is the strongest independent risk factor of 30-day mortality.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200369     DOI: 10.1016/j.athoracsur.2011.07.089

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Biomaterial applications in cardiovascular tissue repair and regeneration.

Authors:  Mai T Lam; Joseph C Wu
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-08

2.  Analysis of postsurgical aortic false aneurysm in 27 patients.

Authors:  Pietro Giorgio Malvindi; Antioco Cappai; Giuseppe Maria Raffa; Alessandro Barbone; Alessio Basciu; Enrico Citterio; Diego Ornaghi; Giuseppe Tarelli; Fabrizio Settepani
Journal:  Tex Heart Inst J       Date:  2013

3.  More than 20-year experience of Bentall operation with mechanical prostheses for chronic aortic root aneurysm.

Authors:  Takahiro Nishida; Hiromichi Sonoda; Yasuhisa Oishi; Tomoki Ushijima; Yoshihisa Tanoue; Atsuhiro Nakashima; Yuichi Shiokawa; Ryuji Tominaga
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-12

4.  Surgical Treatment of Annuloaortic Ectasia - Replace or Repair?

Authors:  Andrea De Martino; Federico Del Re; Stefania Blasi; Michele Celiento; Giacomo Ravenni; Stefano Pratali; Aldo D Milano; Uberto Bortolotti
Journal:  Aorta (Stamford)       Date:  2017-10-01

5.  Long Term Results of the Modified Bentall Procedure With Mechanical and Biological Composite Valve Grafts.

Authors:  Paul Werner; Jasmin Gritsch; Alexandra Kaider; Iuliana Coti; Emilio Osorio; Stephane Mahr; Marie-Elisabeth Stelzmueller; Alfred Kocher; Günther Laufer; Martin Andreas; Marek Ehrlich
Journal:  Front Cardiovasc Med       Date:  2022-04-06

6.  Does additional aortic procedure carry a higher risk in patients undergoing aortic valve replacement?

Authors:  Tae-Hun Kim; Kay-Hyun Park; Jae Suk Yoo; Jae Hang Lee; Cheong Lim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.